Exploration of Lycorine and Copper(II)’s Association with the N-Terminal Domain of Amyloid β
Abstract
:1. Introduction
2. Results
2.1. Study of Aβ16–LYC Interaction
2.2. Study of Aβ16–Cu(II) Interaction
2.3. Study of the Ternary Association between Aβ16, Cu(II), and LYC
3. Discussion
4. Materials and Methods
4.1. Materials
4.2. NMR Experiments
4.3. UV-VIS Measurements
4.4. CD Studies
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Scheltens, P.; De Strooper, B.; Kivipelto, M.; Holstege, H.; Chételat, G.; Teunissen, C.E.; Cummings, J.; van der Flier, W.M. Alzheimer’s Disease. Lancet 2021, 397, 1577–1590. [Google Scholar] [CrossRef]
- Dementia. Available online: https://www.who.int/news-room/fact-sheets/detail/dementia (accessed on 29 September 2023).
- World Health Organization. Global Action Plan on the Public Health Response to Dementia 2017–2025; World Health Organization: Geneva, Switzerland, 2017; ISBN 978-92-4-151348-7. [Google Scholar]
- Scott, T.J.; O’Connor, A.C.; Link, A.N.; Beaulieu, T.J. Economic Analysis of Opportunities to Accelerate Alzheimer’s Disease Research and Development. Ann. N. Y. Acad. Sci. 2014, 1313, 17–34. [Google Scholar] [CrossRef] [PubMed]
- Cummings, J.L.; Morstorf, T.; Zhong, K. Alzheimer’s Disease Drug-Development Pipeline: Few Candidates, Frequent Failures. Alzheimer’s Res. Ther. 2014, 6, 37. [Google Scholar] [CrossRef] [PubMed]
- Cummings, J.; Reiber, C.; Kumar, P. The Price of Progress: Funding and Financing Alzheimer’s Disease Drug Development. A&D Transl. Res. Clin. Interv. 2018, 4, 330–343. [Google Scholar] [CrossRef]
- International, A.D.; Patterson, C. World Alzheimer Report 2018: The State of the Art of Dementia Research: New Frontiers; Alzheimer’s Disease International (ADI): London, UK, 2018. [Google Scholar]
- Xiao, J.; Tundis, R. Natural Products for Alzheimer’s Disease Therapy: Basic and Application. J. Pharm. Pharmacol. 2013, 65, 1679–1680. [Google Scholar] [CrossRef] [PubMed]
- Palmioli, A.; Mazzoni, V.; De Luigi, A.; Bruzzone, C.; Sala, G.; Colombo, L.; Bazzini, C.; Zoia, C.P.; Inserra, M.; Salmona, M.; et al. Alzheimer’s Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity. ACS Chem. Neurosci. 2022, 13, 3152–3167. [Google Scholar] [CrossRef] [PubMed]
- da Rosa, M.M.; de Amorim, L.C.; Alves, J.V.d.O.; Aguiar, I.F.d.S.; Oliveira, F.G.d.S.; da Silva, M.V.; dos Santos, M.T.C. The Promising Role of Natural Products in Alzheimer’s Disease. Brain Disord. 2022, 7, 100049. [Google Scholar] [CrossRef]
- Braak, H.; Thal, D.R.; Ghebremedhin, E.; Del Tredici, K. Stages of the Pathologic Process in Alzheimer Disease: Age Categories from 1 to 100 Years. J. Neuropathol. Exp. Neurol. 2011, 70, 960–969. [Google Scholar] [CrossRef]
- Abate, G.; Vezzoli, M.; Sandri, M.; Rungratanawanich, W.; Memo, M.; Uberti, D. Mitochondria and Cellular Redox State on the Route from Ageing to Alzheimer’s Disease. Mech. Ageing Dev. 2020, 192, 111385. [Google Scholar] [CrossRef]
- Azam, S.; Haque, M.E.; Balakrishnan, R.; Kim, I.-S.; Choi, D.-K. The Ageing Brain: Molecular and Cellular Basis of Neurodegeneration. Front. Cell Dev. Biol. 2021, 9, 683459. [Google Scholar] [CrossRef]
- Talboom, J.S.; Håberg, A.; De Both, M.D.; Naymik, M.A.; Schrauwen, I.; Lewis, C.R.; Bertinelli, S.F.; Hammersland, C.; Fritz, M.A.; Myers, A.J.; et al. Family History of Alzheimer’s Disease Alters Cognition and Is Modified by Medical and Genetic Factors. eLife 2019, 8, e46179. [Google Scholar] [CrossRef]
- Green, R.C.; Cupples, L.A.; Go, R.; Benke, K.S.; Edeki, T.; Griffith, P.A.; Williams, M.; Hipps, Y.; Graff-Radford, N.; Bachman, D.; et al. Risk of Dementia among White and African American Relatives of Patients with Alzheimer Disease. JAMA 2002, 287, 329–336. [Google Scholar] [CrossRef] [PubMed]
- Silva, M.V.F.; Loures, C.d.M.G.; Alves, L.C.V.; de Souza, L.C.; Borges, K.B.G.; das Graças Carvalho, M. Alzheimer’s Disease: Risk Factors and Potentially Protective Measures. J. Biomed. Sci. 2019, 26, 33. [Google Scholar] [CrossRef] [PubMed]
- Bellenguez, C.; Küçükali, F.; Jansen, I.E.; Kleineidam, L.; Moreno-Grau, S.; Amin, N.; Naj, A.C.; Campos-Martin, R.; Grenier-Boley, B.; Andrade, V.; et al. New Insights into the Genetic Etiology of Alzheimer’s Disease and Related Dementias. Nat. Genet. 2022, 54, 412–436. [Google Scholar] [CrossRef]
- Schneider, A.L.C.; Selvin, E.; Latour, L.; Turtzo, L.C.; Coresh, J.; Mosley, T.; Ling, G.; Gottesman, R.F. Head Injury and 25-year Risk of Dementia. Alzheimer’s Dement. 2021, 17, 1432–1441. [Google Scholar] [CrossRef] [PubMed]
- Abubakar, M.B.; Sanusi, K.O.; Ugusman, A.; Mohamed, W.; Kamal, H.; Ibrahim, N.H.; Khoo, C.S.; Kumar, J. Alzheimer’s Disease: An Update and Insights Into Pathophysiology. Front. Aging Neurosci. 2022, 14, 742408. [Google Scholar] [CrossRef]
- Gu, L.; Guo, Z. Alzheimer’s Aβ42 and Aβ40 Peptides Form Interlaced Amyloid Fibrils. J. Neurochem. 2013, 126, 305–311. [Google Scholar] [CrossRef]
- Kepp, K.P.; Robakis, N.K.; Høilund-Carlsen, P.F.; Sensi, S.L.; Vissel, B. The Amyloid Cascade Hypothesis: An Updated Critical Review. Brain 2023, 146, awad159. [Google Scholar] [CrossRef] [PubMed]
- Näslund, J.; Haroutunian, V.; Mohs, R.; Davis, K.L.; Davies, P.; Greengard, P.; Buxbaum, J.D. Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline. JAMA 2000, 283, 1571–1577. [Google Scholar] [CrossRef]
- Falcone, E.; Hureau, C. Redox Processes in Cu-Binding Proteins: The “in-between” States in Intrinsically Disordered Peptides. Chem. Soc. Rev. 2023, 52, 6595–6600. [Google Scholar] [CrossRef]
- Wärmländer, S.K.T.S.; Österlund, N.; Wallin, C.; Wu, J.; Luo, J.; Tiiman, A.; Jarvet, J.; Gräslund, A. Metal Binding to the Amyloid-β Peptides in the Presence of Biomembranes: Potential Mechanisms of Cell Toxicity. J. Biol. Inorg. Chem. 2019, 24, 1189–1196. [Google Scholar] [CrossRef]
- Esmieu, C.; Guettas, D.; Conte-Daban, A.; Sabater, L.; Faller, P.; Hureau, C. Copper-Targeting Approaches in Alzheimer’s Disease: How To Improve the Fallouts Obtained from in Vitro Studies. Inorg. Chem. 2019, 58, 13509–13527. [Google Scholar] [CrossRef]
- Cheignon, C.; Tomas, M.; Bonnefont-Rousselot, D.; Faller, P.; Hureau, C.; Collin, F. Oxidative Stress and the Amyloid Beta Peptide in Alzheimer’s Disease. Redox Biol. 2018, 14, 450–464. [Google Scholar] [CrossRef] [PubMed]
- Buccellato, F.R.; D’Anca, M.; Tartaglia, G.M.; Del Fabbro, M.; Scarpini, E.; Galimberti, D. Treatment of Alzheimer’s Disease: Beyond Symptomatic Therapies. Int. J. Mol. Sci. 2023, 24, 13900. [Google Scholar] [CrossRef] [PubMed]
- Hampel, H.; Mesulam, M.-M.; Cuello, A.C.; Farlow, M.R.; Giacobini, E.; Grossberg, G.T.; Khachaturian, A.S.; Vergallo, A.; Cavedo, E.; Snyder, P.J.; et al. The Cholinergic System in the Pathophysiology and Treatment of Alzheimer’s Disease. Brain 2018, 141, 1917–1933. [Google Scholar] [CrossRef]
- Zemek, F.; Drtinova, L.; Nepovimova, E.; Sepsova, V.; Korabecny, J.; Klimes, J.; Kuca, K. Outcomes of Alzheimer’s Disease Therapy with Acetylcholinesterase Inhibitors and Memantine. Expert. Opin. Drug Saf. 2014, 13, 759–774. [Google Scholar]
- Marucci, G.; Michela Buccioni, M.; Ben, D.D.; Lambertucci, C.; Volpini, R.; Amenta, F. Efficacy of Acetylcholinesterase Inhibitors in Alzheimer’s Disease. Neuropharmacology 2021, 190, 108352. [Google Scholar] [CrossRef]
- Guzior, N.; Wieckowska, A.; Panek, D.; Malawska, B. Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s Disease. Curr. Med. Chem. 2015, 22, 373–404. [Google Scholar] [CrossRef]
- Vrabec, R.; Blunden, G.; Cahlíková, L. Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease. Int. J. Mol. Sci. 2023, 24, 4399. [Google Scholar] [CrossRef] [PubMed]
- Kola, A.; Lamponi, S.; Currò, F.; Valensin, D. A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity. Int. J. Mol. Sci. 2023, 24, 2500. [Google Scholar] [CrossRef] [PubMed]
- Nair, J.J.; van Staden, J. Insight to the Antifungal Properties of Amaryllidaceae Constituents. Phytomedicine 2020, 73, 152753. [Google Scholar] [CrossRef]
- Roy, M.; Liang, L.; Xiao, X.; Feng, P.; Ye, M.; Liu, J. Lycorine: A Prospective Natural Lead for Anticancer Drug Discovery. Biomed. Pharmacother. 2018, 107, 615–624. [Google Scholar] [CrossRef] [PubMed]
- Xiao, H.; Xu, X.; Du, L.; Li, X.; Zhao, H.; Wang, Z.; Zhao, L.; Yang, Z.; Zhang, S.; Yang, Y.; et al. Lycorine and Organ Protection: Review of Its Potential Effects and Molecular Mechanisms. Phytomedicine 2022, 104, 154266. [Google Scholar] [CrossRef] [PubMed]
- Rana, M.; Sharma, A.K. Cu and Zn Interactions with Aβ Peptides: Consequence of Coordination on Aggregation and Formation of Neurotoxic Soluble Aβ Oligomers. Metallomics 2019, 11, 64–84. [Google Scholar] [CrossRef]
- De Gregorio, G.; Biasotto, F.; Hecel, A.; Luczkowski, M.; Kozlowski, H.; Valensin, D. Structural Analysis of Copper(I) Interaction with Amyloid β Peptide. J. Inorg. Biochem. 2019, 195, 31–38. [Google Scholar] [CrossRef] [PubMed]
- Fogolari, F.; Esposito, G.; Viglino, P.; Briggs, J.M.; McCammon, J.A. pKa Shift Effects on Backbone Amide Base-Catalyzed Hydrogen Exchange Rates in Peptides. J. Am. Chem. Soc. 1998, 120, 3735–3738. [Google Scholar] [CrossRef]
- Zirah, S.; Kozin, S.A.; Mazur, A.K.; Blond, A.; Cheminant, M.; Ségalas-Milazzo, I.; Debey, P.; Rebuffat, S. Structural Changes of Region 1-16 of the Alzheimer Disease Amyloid Beta-Peptide upon Zinc Binding and in Vitro Aging. J. Biol. Chem. 2006, 281, 2151–2161. [Google Scholar] [CrossRef]
- Park, S.; Na, C.; Han, J.; Lim, M.H. Methods for Analyzing the Coordination and Aggregation of Metal-Amyloid-β. Metallomics 2023, 15, mfac102. [Google Scholar] [CrossRef]
- Sóvágó, I.; Várnagy, K.; Kállay, C.; Grenács, Á. Interactions of Copper(II) and Zinc(II) Ions with the Peptide Fragments of Proteins Related to Neurodegenerative Disorders: Similarities and Differences. Curr. Med. Chem. 2023, 30, 4050–4071. [Google Scholar] [CrossRef]
- Singh, S.K.; Balendra, V.; Obaid, A.A.; Esposto, J.; Tikhonova, M.A.; Gautam, N.K.; Poeggeler, B. Copper-Mediated β-Amyloid Toxicity and Its Chelation Therapy in Alzheimer’s Disease. Metallomics 2022, 14, mfac018. [Google Scholar] [CrossRef]
- Atrián-Blasco, E.; Del Barrio, M.; Faller, P.; Hureau, C. Ascorbate Oxidation by Cu(Amyloid-β) Complexes: Determination of the Intrinsic Rate as a Function of Alterations in the Peptide Sequence Revealing Key Residues for Reactive Oxygen Species Production. Anal. Chem. 2018, 90, 5909–5915. [Google Scholar] [CrossRef]
- Shen, J.; Griffiths, P.T.; Campbell, S.J.; Utinger, B.; Kalberer, M.; Paulson, S.E. Ascorbate Oxidation by Iron, Copper and Reactive Oxygen Species: Review, Model Development, and Derivation of Key Rate Constants. Sci. Rep. 2021, 11, 7417. [Google Scholar] [CrossRef] [PubMed]
- Kola, A.; Vigni, G.; Baratto, M.C.; Valensin, D. A Combined NMR and UV-Vis Approach to Evaluate Radical Scavenging Activity of Rosmarinic Acid and Other Polyphenols. Molecules 2023, 28, 6629. [Google Scholar] [CrossRef]
- Syme, C.D.; Nadal, R.C.; Rigby, S.E.J.; Viles, J.H. Copper Binding to the Amyloid-Beta (Abeta) Peptide Associated with Alzheimer’s Disease: Folding, Coordination Geometry, pH Dependence, Stoichiometry, and Affinity of Abeta-(1-28): Insights from a Range of Complementary Spectroscopic Techniques. J. Biol. Chem. 2004, 279, 18169–18177. [Google Scholar] [CrossRef] [PubMed]
- Cicero, C.E.; Mostile, G.; Vasta, R.; Rapisarda, V.; Signorelli, S.S.; Ferrante, M.; Zappia, M.; Nicoletti, A. Metals and Neurodegenerative Diseases. A Systematic Review. Environ. Res. 2017, 159, 82–94. [Google Scholar] [CrossRef] [PubMed]
- Kola, A.; Nencioni, F.; Valensin, D. Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases. Molecules 2023, 28, 5467. [Google Scholar] [CrossRef]
- Gaggelli, E.; Kozlowski, H.; Valensin, D.; Valensin, G. Copper Homeostasis and Neurodegenerative Disorders (Alzheimer’s, Prion, and Parkinson’s Diseases and Amyotrophic Lateral Sclerosis). Chem. Rev. 2006, 106, 1995–2044. [Google Scholar] [CrossRef]
- Liu, Y.; Nguyen, M.; Robert, A.; Meunier, B. Metal Ions in Alzheimer’s Disease: A Key Role or Not? Acc. Chem. Res. 2019, 52, 2026–2035. [Google Scholar] [CrossRef]
- Kozlowski, H.; Luczkowski, M.; Remelli, M.; Valensin, D. Copper, Zinc and Iron in Neurodegenerative Diseases (Alzheimer’s, Parkinson’s and Prion Diseases). Coord. Chem. Rev. 2012, 256, 2129–2141. [Google Scholar] [CrossRef]
- Wang, L.; Yin, Y.-L.; Liu, X.-Z.; Shen, P.; Zheng, Y.-G.; Lan, X.-R.; Lu, C.-B.; Wang, J.-Z. Current Understanding of Metal Ions in the Pathogenesis of Alzheimer’s Disease. Transl. Neurodegener. 2020, 9, 10. [Google Scholar] [CrossRef]
- Scolari Grotto, F.; Glaser, V. Are High Copper Levels Related to Alzheimer’s and Parkinson’s Diseases? A Systematic Review and Meta-Analysis of Articles Published between 2011 and 2022. Biometals 2023. [Google Scholar] [CrossRef] [PubMed]
- Wang, Z.-X.; Tan, L.; Wang, H.-F.; Ma, J.; Liu, J.; Tan, M.-S.; Sun, J.-H.; Zhu, X.-C.; Jiang, T.; Yu, J.-T. Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer’s Disease: A Replication Study and Meta-Analyses. J. Alzheimers Dis. 2015, 47, 565–581. [Google Scholar] [CrossRef] [PubMed]
- Atrián-Blasco, E.; Gonzalez, P.; Santoro, A.; Alies, B.; Faller, P.; Hureau, C. Cu and Zn Coordination to Amyloid Peptides: From Fascinating Chemistry to Debated Pathological Relevance. Coord. Chem. Rev. 2018, 375, 38–55. [Google Scholar] [CrossRef]
- Leal, S.S.; Botelho, H.M.; Gomes, C.M. Metal Ions as Modulators of Protein Conformation and Misfolding in Neurodegeneration. Coord. Chem. Rev. 2012, 256, 2253–2270. [Google Scholar] [CrossRef]
- Cherny, R.A.; Atwood, C.S.; Xilinas, M.E.; Gray, D.N.; Jones, W.D.; McLean, C.A.; Barnham, K.J.; Volitakis, I.; Fraser, F.W.; Kim, Y.-S.; et al. Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer’s Disease Transgenic Mice. Neuron 2001, 30, 665–676. [Google Scholar] [CrossRef] [PubMed]
- Mital, M.; Bal, W.; Frączyk, T.; Drew, S.C. Interplay between Copper, Neprilysin, and N-Truncation of β-Amyloid. Inorg. Chem. 2018, 57, 6193–6197. [Google Scholar] [CrossRef]
- Grasso, G.; Pietropaolo, A.; Spoto, G.; Pappalardo, G.; Tundo, G.R.; Ciaccio, C.; Coletta, M.; Rizzarelli, E. Copper(I) and Copper(II) Inhibit Aβ Peptides Proteolysis by Insulin-Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer’s Disease. Chemistry 2011, 17, 2752–2762. [Google Scholar] [CrossRef] [PubMed]
- Cheignon, C.; Jones, M.; Atrián-Blasco, E.; Kieffer, I.; Faller, P.; Collin, F.; Hureau, C. Identification of Key Structural Features of the Elusive Cu-Aβ Complex That Generates ROS in Alzheimer’s Disease. Chem. Sci. 2017, 8, 5107–5118. [Google Scholar] [CrossRef]
- Shen, H.; Dou, Y.; Wang, X.; Wang, X.; Kong, F.; Wang, S. Guluronic Acid Can Inhibit Copper(II) and Amyloid-β Peptide Coordination and Reduce Copper-Related Reactive Oxygen Species Formation Associated with Alzheimer’s Disease. J. Inorg. Biochem. 2023, 245, 112252. [Google Scholar] [CrossRef]
- Birla, H.; Minocha, T.; Kumar, G.; Misra, A.; Singh, S.K. Role of Oxidative Stress and Metal Toxicity in the Progression of Alzheimer’s Disease. Curr. Neuropharmacol. 2020, 18, 552–562. [Google Scholar] [CrossRef]
- Falcone, E.; Nobili, G.; Okafor, M.; Proux, O.; Rossi, G.; Morante, S.; Faller, P.; Stellato, F. Chasing the Elusive “In-Between” State of the Copper-Amyloid β Complex by X-Ray Absorption through Partial Thermal Relaxation after Photoreduction. Angew. Chem. Int. Ed. Engl. 2023, 62, e202217791. [Google Scholar] [CrossRef] [PubMed]
- Jiang, S.; Zhao, Y.; Zhang, T.; Lan, J.; Yang, J.; Yuan, L.; Zhang, Q.; Pan, K.; Zhang, K. Galantamine Inhibits β-Amyloid-Induced Cytostatic Autophagy in PC12 Cells through Decreasing ROS Production. Cell Prolif. 2018, 51, e12427. [Google Scholar] [CrossRef] [PubMed]
- Hwang, T.-L.; Shaka, A.J. Multiple-Pulse Mixing Sequences That Selectively Enhance Chemical Exchange or Cross-Relaxation Peaks in High-Resolution NMR Spectra. J. Magn. Reson. 1998, 135, 280–287. [Google Scholar] [CrossRef]
- Savitzky, A.; Golay, M.J.E. Smoothing and Differentiation of Data by Simplified Least Squares Procedures. Anal. Chem. 1964, 36, 1627–1639. [Google Scholar] [CrossRef]
Atom Type | ppm Values | ||
---|---|---|---|
LYC Protons | LYC | LYC (0.4 eqs) + Aβ | LYC (1.0 eqs) + Aβ |
H12 | 7.03 | 7.03 | 7.03 |
H8 | 6.84 | 6.83 | 6.83 |
H10 | 6.01 | 6.00 | 6.00 |
H3 | 5.74 | 5.73 | 5.73 |
H1 | 4.65 | 4.65 | 4.65 |
H2 | 4.34 | 4.33 | 4.33 |
H7″ | 4.25 | 4.24 | 4.24 |
H7′ | 4.02 | 3.99 (−0.03 ppm) 1 | 4.00 |
H5″ | 3.50 | 3.49 | 3.49 |
H3a1 | 3.33 | 3.29 (−0.04 ppm) 1 | 3.30 |
H12b | 2.88 | 2.87 | 2.87 |
H4 | 2.82 | 2.81 | 2.81 |
H5′ | 2.75 | 2.74 | 2.74 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kola, A.; Vigni, G.; Valensin, D. Exploration of Lycorine and Copper(II)’s Association with the N-Terminal Domain of Amyloid β. Inorganics 2023, 11, 443. https://doi.org/10.3390/inorganics11110443
Kola A, Vigni G, Valensin D. Exploration of Lycorine and Copper(II)’s Association with the N-Terminal Domain of Amyloid β. Inorganics. 2023; 11(11):443. https://doi.org/10.3390/inorganics11110443
Chicago/Turabian StyleKola, Arian, Ginevra Vigni, and Daniela Valensin. 2023. "Exploration of Lycorine and Copper(II)’s Association with the N-Terminal Domain of Amyloid β" Inorganics 11, no. 11: 443. https://doi.org/10.3390/inorganics11110443